National Action Plan For The MHPSS Response To COVID-19

National Action Plan for the MHPSS Response to COVID-19

This action plan was developed as part of the national response to the COVID-19 outbreak. It aims at comprehensively addressing the MHPSS aspects of the COVID-19 outbreak in Lebanon for all persons living in the country. It was developed by the MOPH-National Mental Health Programme (NMHP) with WHO and UNICEF, in line with the IASC Briefing note on addressing mental health and psychosocial aspects of COVID-19 Outbreak- version 1.0 and the local needs, health system and national mental health strategy.

Goals:

Promote mental health and mitigate COVID-19 related stressors including stigma and discrimination against persons affected and health workers.
Provide mental health support to the persons in quarantine in the hospital or at home and their families.
Support the mental health of health workers and first responders in the response.
Ensure continuity of mental health care for persons using mental health services in line with IPC guidelines.

To view the action plan, click here: National Action Plan for MHPSS Response to COVID-19

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
J01DH02	MERO CARE	G	Meropenem - 1g	1g	Injectable powder for solution	643,701 L.L
J01DH02	MEROLIN	G	Meropenem (trihydrate) - 1g	1g	Injectable powder for solution	2,402,668 L.L
J01DH02	MEROPENEM LABATEC	G	Meropenem (trihydrate) - 1g	1g	Injectable powder for solution	7,278,513 L.L
J01DH02	MEROPENEM MEDIS	G	Meropenem (trihydrate) - 1g	1g	Injectable powder for solution	6,443,725 L.L
J01DH02	MEROPENEM PANPHARMA	G	Meropenem (trihydrate) - 1g	1g	Injectable powder for solution	7,278,513 L.L
J01DH02	MEROPENEM/ ANFARM	G	Meropenem (trihydrate) - 1g	1g	Injectable powder for solution	6,443,725 L.L
J01DH02	MEROZAN	G	Meropenem - 1g	1g	Injectable powder for solution	6,443,725 L.L
J01DH02	MIRAN	G	Meropenem (trihydrate) - 1g	1g	Injectable powder for solution	819,744 L.L
J01DD04	MEGION-A	G	Ceftriaxone - 1g/3.5ml, Lidocaine (ampoule) -	1g/3.5ml	Injectable powder + solvent	623,468 L.L
N02AA01	MORPHINE (CHLORHYDRATE) RENAUDIN	G	Morphine HCl - 1mg/ml	1mg/ml	Injectable solution	626,231 L.L
C01CE02	MILRINONE	G	Milrinone - 1mg/ml	1mg/ml	Injectable concentrate for solution	28,486,446 L.L
D11AX01	MINOXIDIL BAILLEUL	G	Minoxidil - 2%	2%	Solution	2,839,539 L.L
G01AF04	MYCODERM-V	G	Miconazole nitrate - 2%	2%	Cream	361,494 L.L
A10BX16	MOUNJARO KWIKPEN	B	Tirzepatide - 2.5mg/dose	2.5mg/dose	Injectable solution	39,601,065 L.L
B05BC01	MANNITOL 20% INJECTION USP	G	Mannitol - 20%	20%	Injectable solution	613,662 L.L
B05BC01	MANNITOL 20% INJECTION USP	G	Mannitol - 20%	20%	Injectable solution	344,754 L.L
B05BC01	MANNITOL 20% INJECTION USP	G	Mannitol - 20%	20%	Injectable solution	374,633 L.L
A07AA02	MEDISTAN	G	Nystatin - 200.000IU	200.000IU	Lozenge	418,511 L.L
H05BA01	MIACALCIC 200 UI/ACTUATION	B	Calcitonin (salmon synthetic) - 200IU/actuation	200IU/actuation	Solution	5,399,559 L.L
A02BB01	MISOFAR	G	Misoprostol - 200mcg	200mcg	Tablet	1,546,763 L.L
J01DD08	MUREX 200	G	Cefixime - 200mg	200mg	Capsule	430,030 L.L
P01AB01	METROGYL	G	Metronidazole benzoate - 200mg/5ml	200mg/5ml	Powder for suspension	500,867 L.L
R02A	MAXILASE MAUX DE GORGE	B	Alpha-Amylase - 200U.CEIP/ml	200U.CEIP/ml	Syrup	342,680 L.L
B05BC01	MANNITOL 20% INJECTION, USP	G	Mannitol - 20g/100ml	20g/100ml	Injectable solution	402,213 L.L
B05BC01	MANNITOL 20% INJECTION, USP	G	Mannitol - 20g/100ml	20g/100ml	Injectable solution	402,213 L.L
B05BC01	MANNITOL	G	Mannitol - 20g/100ml	20g/100ml	Injectable solution	406,810 L.L
B05BC01	MANNITOL	G	Mannitol - 20g/100ml	20g/100ml	Injectable solution	579,064 L.L
B05BC01	MANNITOL	G	Mannitol - 20g/100ml	20g/100ml	Injectable solution	613,662 L.L
G02BA03	MIRENA 20mcg/24h Levonorgestrel	B	Levonorgestrel - 20mcg/24h	20mcg/24h	Implant	10,530,753 L.L
N06DX01	MEMANTINE ARROW LAB	G	Memantine HCl - 20mg	20mg	Tablet, film coated	1,342,499 L.L

...